Dr. Juan Camilo Arjona Ferreira - 31 Mar 2025 Form 4 Insider Report for Organon & Co. (OGN)

Role
Head of R&D & CMO
Signature
/s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Issuer symbol
OGN
Transactions as of
31 Mar 2025
Net transactions value
-$46,026
Form type
4
Filing time
02 Apr 2025, 17:40:55 UTC
Previous filing
08 Nov 2024
Next filing
12 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +8,865 +76% $0.000000 20,552 31 Mar 2025 Direct
transaction OGN Common Stock Tax liability $46,026 -3,172 -15% $14.51 17,380 31 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Stock Option (right to buy) Award $0 +198,019 $0.000000 198,019 31 Mar 2025 Common Stock 198,019 $14.89 Direct F2, F3
transaction OGN Restricted Stock Units Award $0 +40,295 $0.000000 40,295 31 Mar 2025 Common Stock 40,295 Direct F2, F4
transaction OGN Restricted Stock Units Options Exercise $0 -8,865 -33% $0.000000 17,730 31 Mar 2025 Common Stock 8,865 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
F2 Each RSU converts into one share of Organon common stock.
F3 The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
F4 The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
F5 On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.